ID ACTN3_HUMAN Reviewed; 901 AA. AC Q08043; A6NP77; Q4KKV2; DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot. DT 25-NOV-2008, sequence version 2. DT 24-JAN-2024, entry version 201. DE RecName: Full=Alpha-actinin-3; DE AltName: Full=Alpha-actinin skeletal muscle isoform 3; DE AltName: Full=F-actin cross-linking protein; GN Name=ACTN3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS GLN-523; ARG-628 AND ARG-776. RC TISSUE=Skeletal muscle; RX PubMed=1339456; DOI=10.1016/s0021-9258(19)50420-3; RA Beggs A.H., Byers T.J., Knoll J.H.M., Boyce F.M., Bruns G.A.P., RA Kunkel L.M.; RT "Cloning and characterization of two human skeletal muscle alpha-actinin RT genes located on chromosomes 1 and 11."; RL J. Biol. Chem. 267:9281-9288(1992). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16554811; DOI=10.1038/nature04632; RA Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., RA Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., RA Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G., RA Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C., RA Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A., RA Hattori M., Rogers J., Lander E.S., Sakaki Y.; RT "Human chromosome 11 DNA sequence and analysis including novel gene RT identification."; RL Nature 440:497-500(2006). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLN-523; ARG-628 AND RP ARG-776. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP TISSUE SPECIFICITY, AND POLYMORPHISM. RX PubMed=11440986; DOI=10.1093/hmg/10.13.1335; RA Mills M., Yang N., Weinberger R., Vander Woude D.L., Beggs A.H., RA Easteal S., North K.N.; RT "Differential expression of the actin-binding proteins, alpha-actinin-2 and RT -3, in different species: implications for the evolution of functional RT redundancy."; RL Hum. Mol. Genet. 10:1335-1346(2001). RN [5] RP INTERACTION WITH MYOZ1. RX PubMed=11171996; DOI=10.1073/pnas.98.4.1595; RA Takada F., Vander Woude D.L., Tong H.-Q., Thompson T.G., Watkins S.C., RA Kunkel L.M., Beggs A.H.; RT "Myozenin: an alpha-actinin- and gamma-filamin-binding protein of skeletal RT muscle Z lines."; RL Proc. Natl. Acad. Sci. U.S.A. 98:1595-1600(2001). RN [6] RP ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=22223895; DOI=10.1074/mcp.m111.015131; RA Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T., RA Giglione C.; RT "Comparative large-scale characterisation of plant vs. mammal proteins RT reveals similar and idiosyncratic N-alpha acetylation features."; RL Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012). RN [7] RP X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 26-273. RX PubMed=15808860; DOI=10.1016/j.jmb.2005.01.002; RA Franzot G., Sjoblom B., Gautel M., Djinovic Carugo K.; RT "The crystal structure of the actin binding domain from alpha-actinin in RT its closed conformation: structural insight into phospholipid regulation of RT alpha-actinin."; RL J. Mol. Biol. 348:151-165(2005). RN [8] RP VARIANTS GLN-523 AND 577-ARG--LEU-901 DEL, AND POLYMORPHISM. RX PubMed=10192379; DOI=10.1038/7675; RA North K.N., Yang N., Wattanasirichaigoon D., Mills M., Easteal S., RA Beggs A.H.; RT "A common nonsense mutation results in alpha-actinin-3 deficiency in the RT general population."; RL Nat. Genet. 21:353-354(1999). CC -!- FUNCTION: F-actin cross-linking protein which is thought to anchor CC actin to a variety of intracellular structures. This is a bundling CC protein. CC -!- SUBUNIT: Homodimer; antiparallel. Also forms heterodimers with ACTN2. CC Interacts with MYOZ1. {ECO:0000269|PubMed:11171996}. CC -!- INTERACTION: CC Q08043; P12814: ACTN1; NbExp=3; IntAct=EBI-2880652, EBI-351710; CC Q08043; Q08043: ACTN3; NbExp=3; IntAct=EBI-2880652, EBI-2880652; CC Q08043; O43707: ACTN4; NbExp=3; IntAct=EBI-2880652, EBI-351526; CC Q08043; Q96DX5: ASB9; NbExp=3; IntAct=EBI-2880652, EBI-745641; CC Q08043; Q9Y6H3: ATP23; NbExp=3; IntAct=EBI-2880652, EBI-12811889; CC Q08043; Q53TS8: C2CD6; NbExp=3; IntAct=EBI-2880652, EBI-739879; CC Q08043; A2RRN7: CADPS; NbExp=3; IntAct=EBI-2880652, EBI-10179719; CC Q08043; A8MYP8: CIMAP1B; NbExp=3; IntAct=EBI-2880652, EBI-12010090; CC Q08043; Q9H1P6: CIMIP1; NbExp=3; IntAct=EBI-2880652, EBI-12155483; CC Q08043; P78358: CTAG1B; NbExp=5; IntAct=EBI-2880652, EBI-1188472; CC Q08043; Q9GZU7: CTDSP1; NbExp=3; IntAct=EBI-2880652, EBI-751587; CC Q08043; P42830: CXCL5; NbExp=3; IntAct=EBI-2880652, EBI-12175919; CC Q08043; O95865: DDAH2; NbExp=3; IntAct=EBI-2880652, EBI-749139; CC Q08043; Q16610: ECM1; NbExp=3; IntAct=EBI-2880652, EBI-947964; CC Q08043; Q86YD7: FAM90A1; NbExp=3; IntAct=EBI-2880652, EBI-6658203; CC Q08043; Q9BZE0: GLIS2; NbExp=3; IntAct=EBI-2880652, EBI-7251368; CC Q08043; O14964: HGS; NbExp=3; IntAct=EBI-2880652, EBI-740220; CC Q08043; P35452-2: HOXD12; NbExp=3; IntAct=EBI-2880652, EBI-17244356; CC Q08043; O75031: HSF2BP; NbExp=3; IntAct=EBI-2880652, EBI-7116203; CC Q08043; P26440: IVD; NbExp=3; IntAct=EBI-2880652, EBI-2866408; CC Q08043; P48668: KRT6C; NbExp=3; IntAct=EBI-2880652, EBI-2564105; CC Q08043; Q9UBR4-2: LHX3; NbExp=5; IntAct=EBI-2880652, EBI-12039345; CC Q08043; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-2880652, EBI-739832; CC Q08043; P43360: MAGEA6; NbExp=3; IntAct=EBI-2880652, EBI-1045155; CC Q08043; Q8IY33: MICALL2; NbExp=3; IntAct=EBI-2880652, EBI-2555563; CC Q08043; Q9UBF9: MYOT; NbExp=3; IntAct=EBI-2880652, EBI-296701; CC Q08043; Q9NP98: MYOZ1; NbExp=3; IntAct=EBI-2880652, EBI-744402; CC Q08043; O14561: NDUFAB1; NbExp=3; IntAct=EBI-2880652, EBI-1246261; CC Q08043; Q6ZUT1: NKAPD1; NbExp=3; IntAct=EBI-2880652, EBI-3920396; CC Q08043; P05166: PCCB; NbExp=3; IntAct=EBI-2880652, EBI-1371908; CC Q08043; Q99959-2: PKP2; NbExp=3; IntAct=EBI-2880652, EBI-10987518; CC Q08043; P78424: POU6F2; NbExp=3; IntAct=EBI-2880652, EBI-12029004; CC Q08043; Q6NYC8: PPP1R18; NbExp=3; IntAct=EBI-2880652, EBI-2557469; CC Q08043; Q13882: PTK6; NbExp=3; IntAct=EBI-2880652, EBI-1383632; CC Q08043; Q14D33: RTP5; NbExp=3; IntAct=EBI-2880652, EBI-10217913; CC Q08043; O95863: SNAI1; NbExp=3; IntAct=EBI-2880652, EBI-1045459; CC Q08043; Q5JUK2: SOHLH1; NbExp=3; IntAct=EBI-2880652, EBI-12288855; CC Q08043; Q9H987-2: SYNPO2L; NbExp=3; IntAct=EBI-2880652, EBI-12082116; CC Q08043; Q13077: TRAF1; NbExp=3; IntAct=EBI-2880652, EBI-359224; CC Q08043; Q14134: TRIM29; NbExp=3; IntAct=EBI-2880652, EBI-702370; CC Q08043; O75604: USP2; NbExp=3; IntAct=EBI-2880652, EBI-743272; CC Q08043; Q6P1L6: ZNF343; NbExp=3; IntAct=EBI-2880652, EBI-10252492; CC Q08043; Q9BUY5: ZNF426; NbExp=3; IntAct=EBI-2880652, EBI-743265; CC -!- TISSUE SPECIFICITY: Expressed only in a subset of type 2 skeletal CC muscle fibers. {ECO:0000269|PubMed:11440986}. CC -!- POLYMORPHISM: The sequence shown in this entry differs from the CC translation of the reference genome assembly (GRCh38/hg38) due to a CC nonsense variant creating stop codon at position 577 in the reference CC genome, leading to ACTN3 deficiency. However, the presence of this CC variant is not associated with any disease phenotype [MIM:617749]. The CC sequence shown in this entry is that of variant p.Ter577Arg, which has CC a frequency of about 62% in the human population according to the CC Genome Aggregation Database (gnomAD v3.1.2). CC {ECO:0000269|PubMed:10192379}. CC -!- SIMILARITY: Belongs to the alpha-actinin family. {ECO:0000305}. CC -!- CAUTION: The sequence shown in this entry differs from the translation CC of the reference genome assembly (GRCh38/hg38) due to a nonsense CC variant creating stop codon at position 577 in the reference genome. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M86407; AAA51585.1; -; mRNA. DR EMBL; AP002748; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC099647; AAH99647.1; -; mRNA. DR EMBL; BC099649; AAH99649.1; -; mRNA. DR CCDS; CCDS53663.1; -. DR PIR; B40199; FAHUA3. DR RefSeq; NP_001095.2; NM_001104.3. DR RefSeq; NP_001245300.2; NM_001258371.2. DR PDB; 1TJT; X-ray; 2.19 A; A=26-273. DR PDB; 1WKU; X-ray; 1.60 A; A/B=26-273. DR PDB; 3LUE; EM; -; K/L/M/N/O/P/Q/R/S/T=42-150. DR PDBsum; 1TJT; -. DR PDBsum; 1WKU; -. DR PDBsum; 3LUE; -. DR AlphaFoldDB; Q08043; -. DR EMDB; EMD-5170; -. DR SMR; Q08043; -. DR BioGRID; 106604; 101. DR IntAct; Q08043; 58. DR MINT; Q08043; -. DR STRING; 9606.ENSP00000422007; -. DR GlyGen; Q08043; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q08043; -. DR PhosphoSitePlus; Q08043; -. DR SwissPalm; Q08043; -. DR BioMuta; ACTN3; -. DR DMDM; 215273967; -. DR EPD; Q08043; -. DR jPOST; Q08043; -. DR MassIVE; Q08043; -. DR MaxQB; Q08043; -. DR PaxDb; 9606-ENSP00000422007; -. DR PeptideAtlas; Q08043; -. DR PRIDE; Q08043; -. DR ProteomicsDB; 58566; -. DR Pumba; Q08043; -. DR Antibodypedia; 73518; 296 antibodies from 30 providers. DR DNASU; 89; -. DR Ensembl; ENST00000513398.2; ENSP00000426797.1; ENSG00000248746.6. DR GeneID; 89; -. DR KEGG; hsa:89; -. DR MANE-Select; ENST00000513398.2; ENSP00000426797.1; NM_001104.4; NP_001095.2. DR UCSC; uc021qlz.4; human. DR AGR; HGNC:165; -. DR CTD; 89; -. DR DisGeNET; 89; -. DR GeneCards; ACTN3; -. DR HGNC; HGNC:165; ACTN3. DR HPA; ENSG00000248746; Tissue enriched (skeletal). DR MalaCards; ACTN3; -. DR MIM; 102574; phenotype. DR MIM; 617749; phenotype. DR neXtProt; NX_Q08043; -. DR OpenTargets; ENSG00000248746; -. DR PharmGKB; PA24485; -. DR VEuPathDB; HostDB:ENSG00000248746; -. DR eggNOG; KOG0035; Eukaryota. DR GeneTree; ENSGT00940000153968; -. DR HOGENOM; CLU_005217_1_1_1; -. DR InParanoid; Q08043; -. DR OMA; RMTKYTG; -. DR OrthoDB; 2872403at2759; -. DR PhylomeDB; Q08043; -. DR PathwayCommons; Q08043; -. DR Reactome; R-HSA-373753; Nephrin family interactions. DR Reactome; R-HSA-390522; Striated Muscle Contraction. DR SignaLink; Q08043; -. DR BioGRID-ORCS; 89; 7 hits in 233 CRISPR screens. DR ChiTaRS; ACTN3; human. DR EvolutionaryTrace; Q08043; -. DR GeneWiki; ACTN3; -. DR GenomeRNAi; 89; -. DR Pharos; Q08043; Tbio. DR PRO; PR:Q08043; -. DR Proteomes; UP000005640; Chromosome 11. DR RNAct; Q08043; Protein. DR Bgee; ENSG00000248746; Expressed in skeletal muscle tissue of rectus abdominis and 100 other cell types or tissues. DR ExpressionAtlas; Q08043; baseline and differential. DR GO; GO:0005884; C:actin filament; TAS:ProtInc. DR GO; GO:0005903; C:brush border; IEA:Ensembl. DR GO; GO:0030054; C:cell junction; IBA:GO_Central. DR GO; GO:0042995; C:cell projection; IBA:GO_Central. DR GO; GO:0030864; C:cortical actin cytoskeleton; IBA:GO_Central. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0005925; C:focal adhesion; IMP:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0031143; C:pseudopodium; TAS:UniProtKB. DR GO; GO:0030018; C:Z disc; IBA:GO_Central. DR GO; GO:0051015; F:actin filament binding; IBA:GO_Central. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0042802; F:identical protein binding; IPI:IntAct. DR GO; GO:0005178; F:integrin binding; TAS:UniProtKB. DR GO; GO:0008307; F:structural constituent of muscle; TAS:ProtInc. DR GO; GO:0044325; F:transmembrane transporter binding; IPI:UniProtKB. DR GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central. DR GO; GO:0060349; P:bone morphogenesis; IEA:Ensembl. DR GO; GO:0048041; P:focal adhesion assembly; IMP:UniProtKB. DR GO; GO:0055001; P:muscle cell development; IBA:GO_Central. DR GO; GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; ISS:UniProtKB. DR GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab. DR GO; GO:0045820; P:negative regulation of glycolytic process; ISS:UniProtKB. DR GO; GO:0090324; P:negative regulation of oxidative phosphorylation; ISS:UniProtKB. DR GO; GO:1901078; P:negative regulation of relaxation of muscle; IEA:Ensembl. DR GO; GO:1900159; P:positive regulation of bone mineralization involved in bone maturation; IEA:Ensembl. DR GO; GO:0031448; P:positive regulation of fast-twitch skeletal muscle fiber contraction; IEA:Ensembl. DR GO; GO:1904025; P:positive regulation of glucose catabolic process to lactate via pyruvate; ISS:UniProtKB. DR GO; GO:0048743; P:positive regulation of skeletal muscle fiber development; IEA:Ensembl. DR GO; GO:0048633; P:positive regulation of skeletal muscle tissue growth; ISS:UniProtKB. DR GO; GO:1903715; P:regulation of aerobic respiration; ISS:UniProtKB. DR GO; GO:0042981; P:regulation of apoptotic process; NAS:UniProtKB. DR GO; GO:0014728; P:regulation of the force of skeletal muscle contraction; ISS:UniProtKB. DR GO; GO:0014894; P:response to denervation involved in regulation of muscle adaptation; ISS:UniProtKB. DR GO; GO:0014732; P:skeletal muscle atrophy; ISS:UniProtKB. DR GO; GO:0014883; P:transition between fast and slow fiber; ISS:UniProtKB. DR CDD; cd21214; CH_ACTN_rpt1; 1. DR CDD; cd21216; CH_ACTN_rpt2; 1. DR CDD; cd00051; EFh; 1. DR CDD; cd00176; SPEC; 3. DR Gene3D; 1.20.58.60; -; 4. DR Gene3D; 1.10.418.10; Calponin-like domain; 2. DR Gene3D; 1.10.238.10; EF-hand; 2. DR InterPro; IPR001589; Actinin_actin-bd_CS. DR InterPro; IPR001715; CH_dom. DR InterPro; IPR036872; CH_dom_sf. DR InterPro; IPR011992; EF-hand-dom_pair. DR InterPro; IPR014837; EF-hand_Ca_insen. DR InterPro; IPR002048; EF_hand_dom. DR InterPro; IPR018159; Spectrin/alpha-actinin. DR InterPro; IPR002017; Spectrin_repeat. DR PANTHER; PTHR11915:SF432; ALPHA-ACTININ-3; 1. DR PANTHER; PTHR11915; SPECTRIN/FILAMIN RELATED CYTOSKELETAL PROTEIN; 1. DR Pfam; PF00307; CH; 2. DR Pfam; PF08726; EFhand_Ca_insen; 1. DR Pfam; PF00435; Spectrin; 4. DR SMART; SM00033; CH; 2. DR SMART; SM00054; EFh; 2. DR SMART; SM01184; efhand_Ca_insen; 1. DR SMART; SM00150; SPEC; 2. DR SUPFAM; SSF47576; Calponin-homology domain, CH-domain; 1. DR SUPFAM; SSF47473; EF-hand; 1. DR SUPFAM; SSF46966; Spectrin repeat; 4. DR PROSITE; PS00019; ACTININ_1; 1. DR PROSITE; PS00020; ACTININ_2; 1. DR PROSITE; PS50021; CH; 2. DR PROSITE; PS50222; EF_HAND_2; 2. DR Genevisible; Q08043; HS. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Actin-binding; Calcium; Metal-binding; KW Reference proteome; Repeat. FT CHAIN 1..901 FT /note="Alpha-actinin-3" FT /id="PRO_0000073438" FT DOMAIN 45..149 FT /note="Calponin-homology (CH) 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00044" FT DOMAIN 158..264 FT /note="Calponin-homology (CH) 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00044" FT REPEAT 288..398 FT /note="Spectrin 1" FT REPEAT 408..513 FT /note="Spectrin 2" FT REPEAT 523..634 FT /note="Spectrin 3" FT REPEAT 644..747 FT /note="Spectrin 4" FT DOMAIN 760..795 FT /note="EF-hand 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 796..831 FT /note="EF-hand 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT REGION 1..261 FT /note="Actin-binding" FT BINDING 773 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000305" FT BINDING 777 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000305" FT BINDING 779 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000305" FT BINDING 784 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000305" FT BINDING 809 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000305" FT BINDING 811 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000305" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0007744|PubMed:22223895" FT VARIANT 523 FT /note="R -> Q (in dbSNP:rs1671064)" FT /evidence="ECO:0000269|PubMed:10192379, FT ECO:0000269|PubMed:1339456, ECO:0000269|PubMed:15489334" FT /id="VAR_012705" FT VARIANT 577..901 FT /note="Missing (in dbSNP:rs1815739)" FT /evidence="ECO:0000269|PubMed:10192379" FT /id="VAR_080044" FT VARIANT 628 FT /note="C -> R (in dbSNP:rs618838)" FT /evidence="ECO:0000269|PubMed:1339456, FT ECO:0000269|PubMed:15489334" FT /id="VAR_047528" FT VARIANT 635 FT /note="E -> A (in dbSNP:rs2229456)" FT /id="VAR_033488" FT VARIANT 776 FT /note="Q -> R (in dbSNP:rs540874)" FT /evidence="ECO:0000269|PubMed:1339456, FT ECO:0000269|PubMed:15489334" FT /id="VAR_047529" FT HELIX 43..59 FT /evidence="ECO:0007829|PDB:1WKU" FT HELIX 60..62 FT /evidence="ECO:0007829|PDB:1WKU" FT TURN 69..75 FT /evidence="ECO:0007829|PDB:1WKU" FT HELIX 77..87 FT /evidence="ECO:0007829|PDB:1WKU" FT HELIX 100..115 FT /evidence="ECO:0007829|PDB:1WKU" FT TURN 116..118 FT /evidence="ECO:0007829|PDB:1WKU" FT HELIX 126..131 FT /evidence="ECO:0007829|PDB:1WKU" FT HELIX 134..149 FT /evidence="ECO:0007829|PDB:1WKU" FT TURN 150..152 FT /evidence="ECO:0007829|PDB:1WKU" FT HELIX 160..172 FT /evidence="ECO:0007829|PDB:1WKU" FT STRAND 182..184 FT /evidence="ECO:0007829|PDB:1WKU" FT HELIX 185..187 FT /evidence="ECO:0007829|PDB:1WKU" FT HELIX 191..200 FT /evidence="ECO:0007829|PDB:1WKU" FT TURN 202..204 FT /evidence="ECO:0007829|PDB:1TJT" FT HELIX 207..209 FT /evidence="ECO:0007829|PDB:1WKU" FT HELIX 215..229 FT /evidence="ECO:0007829|PDB:1WKU" FT HELIX 238..243 FT /evidence="ECO:0007829|PDB:1WKU" FT STRAND 244..246 FT /evidence="ECO:0007829|PDB:1WKU" FT HELIX 249..265 FT /evidence="ECO:0007829|PDB:1WKU" SQ SEQUENCE 901 AA; 103241 MW; C49B7885E7E1EDA7 CRC64; MMMVMQPEGL GAGEGRFAGG GGGGEYMEQE EDWDRDLLLD PAWEKQQRKT FTAWCNSHLR KAGTQIENIE EDFRNGLKLM LLLEVISGER LPRPDKGKMR FHKIANVNKA LDFIASKGVK LVSIGAEEIV DGNLKMTLGM IWTIILRFAI QDISVEETSA KEGLLLWCQR KTAPYRNVNV QNFHTSWKDG LALCALIHRH RPDLIDYAKL RKDDPIGNLN TAFEVAEKYL DIPKMLDAED IVNTPKPDEK AIMTYVSCFY HAFAGAEQAE TAANRICKVL AVNQENEKLM EEYEKLASEL LEWIRRTVPW LENRVGEPSM SAMQRKLEDF RDYRRLHKPP RIQEKCQLEI NFNTLQTKLR LSHRPAFMPS EGKLVSDIAN AWRGLEQVEK GYEDWLLSEI RRLQRLQHLA EKFRQKASLH EAWTRGKEEM LSQRDYDSAL LQEVRALLRR HEAFESDLAA HQDRVEHIAA LAQELNELDY HEAASVNSRC QAICDQWDNL GTLTQKRRDA LERMEKLLET IDRLQLEFAR RAAPFNNWLD GAVEDLQDVW LVHSVEETQS LLTAHDQFKA TLPEADRERG AIMGIQGEIQ KICQTYGLRP CSTNPYITLS PQDINTKWDM VRKLVPSCDQ TLQEELARQQ VNERLRRQFA AQANAIGPWI QAKVEEVGRL AAGLAGSLEE QMAGLRQQEQ NIINYKTNID RLEGDHQLLQ ESLVFDNKHT VYSMEHIRVG WEQLLTSIAR TINEVENQVL TRDAKGLSQE QLNEFRASFN HFDRKQNGMM EPDDFRACLI SMGYDLGEVE FARIMTMVDP NAAGVVTFQA FIDFMTRETA ETDTTEQVVA SFKILAGDKN YITPEELRRE LPAKQAEYCI RRMVPYKGSG APAGALDYVA FSSALYGESD L //